1. Home
  2. MASI vs RGEN Comparison

MASI vs RGEN Comparison

Compare MASI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MASI
  • RGEN
  • Stock Information
  • Founded
  • MASI 1989
  • RGEN 1981
  • Country
  • MASI United States
  • RGEN United States
  • Employees
  • MASI N/A
  • RGEN N/A
  • Industry
  • MASI Medical/Dental Instruments
  • RGEN Medical/Dental Instruments
  • Sector
  • MASI Health Care
  • RGEN Health Care
  • Exchange
  • MASI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • MASI 8.1B
  • RGEN 6.5B
  • IPO Year
  • MASI 2007
  • RGEN N/A
  • Fundamental
  • Price
  • MASI $147.44
  • RGEN $113.54
  • Analyst Decision
  • MASI Buy
  • RGEN Buy
  • Analyst Count
  • MASI 6
  • RGEN 10
  • Target Price
  • MASI $194.60
  • RGEN $163.78
  • AVG Volume (30 Days)
  • MASI 587.8K
  • RGEN 683.5K
  • Earning Date
  • MASI 11-04-2025
  • RGEN 11-11-2025
  • Dividend Yield
  • MASI N/A
  • RGEN N/A
  • EPS Growth
  • MASI N/A
  • RGEN N/A
  • EPS
  • MASI N/A
  • RGEN N/A
  • Revenue
  • MASI $2,153,800,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • MASI N/A
  • RGEN $16.74
  • Revenue Next Year
  • MASI $7.80
  • RGEN $13.86
  • P/E Ratio
  • MASI N/A
  • RGEN N/A
  • Revenue Growth
  • MASI 25.86
  • RGEN 8.73
  • 52 Week Low
  • MASI $111.03
  • RGEN $102.97
  • 52 Week High
  • MASI $194.88
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • MASI 49.79
  • RGEN 40.89
  • Support Level
  • MASI $144.63
  • RGEN $117.18
  • Resistance Level
  • MASI $149.35
  • RGEN $122.71
  • Average True Range (ATR)
  • MASI 3.79
  • RGEN 4.36
  • MACD
  • MASI 1.08
  • RGEN -0.55
  • Stochastic Oscillator
  • MASI 82.82
  • RGEN 6.59

About MASI Masimo Corporation

Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: